*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Doxylamine succinate combined with Pyridoxine Hydrochloride is a pharmaceutical excipient blend primarily utilized in antiemetic formulations. The core process involves precise salt formation and micronization to ensure stability. Key parameters include molecular formula C18H23N2O2+·C5H6NO4- for Doxylamine succinate and C8H11NO3 for Pyridoxine HCl.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Support:</strong> Management of chemotherapy-induced nausea and vomiting (CINV).</li>
<li><strong>Pregnancy Care:</strong> First-line treatment for morning sickness and hyperemesis gravidarum.</li>
<li><strong>Gastroenterology:</strong> Adjunct therapy for motion sickness and general gastrointestinal distress.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated in patients with narrow-angle glaucoma or urinary retention. Store in cool, dry conditions below 25°C protected from light. Adhere to GMP guidelines during handling to prevent cross-contamination and ensure operator safety via PPE.</p>